The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and the resulting Coronavirus disease 2019 emerged in late 2019 and is responsible for significant morbidity and mortality worldwide. A hallmark of severe COVID‐19 is exaggerated systemic inflammation, regarded as a “cyt...

Full description

Bibliographic Details
Published in:	Pharmacology Research & Perspectives
Main Authors:	Kiran Deshpande, Keith R. Lange, William B. Stone, Christine Yohn, Naomi Schlesinger, Leonid Kagan, Albert J. Auguste, Bonnie L. Firestein, Luigi Brunetti
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Subjects:	COVID‐19 drug transporters drug‐metabolizing enzymes hACE2 SARS‐CoV‐2
Online Access:	https://doi.org/10.1002/prp2.1071

Similar Items

Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
by: Lidia Sánchez-Morales, et al.
Published: (2024-05-01)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
by: Pratima Kumari, et al.
Published: (2021-01-01)

Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19
by: Shasha Liu, et al.
Published: (2024-05-01)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
by: Liat Bar-On, et al.
Published: (2022-04-01)

The protection of CoronaVac against the infection of wild‐type SARS‐CoV‐2 (WH‐09) or Omicron variant in nude‐hACE2 mice
by: Kaili Lin, et al.
Published: (2023-08-01)

Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
by: Kátia Nunes da Silva, et al.
Published: (2025-01-01)

Primary leptomeningeal histiocytic lymphoproliferative disorder associated with SARS-CoV-2 brain infection in k18-hACE2 mouse: a case report
by: Néstor Porras, et al.
Published: (2025-09-01)

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
by: Sabrina Clever, et al.
Published: (2024-03-01)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
by: Simona Dedoni, et al.
Published: (2022-06-01)

Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
by: Chaja Katzman, et al.
Published: (2021-12-01)

The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
by: Yixin Xie, et al.
Published: (2022-02-01)

Enhancing human ACE2 expression in mouse models to improve COVID‐19 research
by: Sun Jiaoyang, et al.
Published: (2025-02-01)

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
by: Romal Stewart, et al.
Published: (2023-11-01)

Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study
by: Aria Gheeraert, et al.
Published: (2025-04-01)

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
by: Mayara Mattos, et al.
Published: (2024-11-01)

Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
by: Yinon Levy, et al.
Published: (2022-02-01)

Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
by: Inna V. Dolzhikova, et al.
Published: (2024-10-01)

Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein
by: Marc Sevenich, et al.
Published: (2022-02-01)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
by: Yasmin da Silva Santos, et al.
Published: (2023-04-01)

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
by: Zhen Zhang, et al.
Published: (2024-12-01)

Post‐COVID pulmonary injury in K18‐hACE2 mice shows persistent neutrophils and neutrophil extracellular trap formation
by: Stefanos Giannakopoulos, et al.
Published: (2024-08-01)

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
by: Momtchilo Russo, et al.
Published: (2023-11-01)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
by: Yfat Yahalom-Ronen, et al.
Published: (2023-06-01)

Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice
by: Ji-Hun Lee, et al.
Published: (2024-11-01)

Recent advances in chemometric modelling of inhibitors against SARS-CoV-2
by: Qianqian Wang, et al.
Published: (2024-01-01)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
by: Hila Gutman, et al.
Published: (2022-07-01)

Spatiotemporal Characterization of Changes in the Respiratory Tract and the Nervous System, Including the Eyes in SARS-CoV-2-Infected K18-hACE2 Mice
by: Malgorzata Rosiak, et al.
Published: (2025-07-01)

Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 miceResearch in context
by: Jiang-Feng Liu, et al.
Published: (2023-04-01)

Differential responses of lung and intestinal microbiota to SARS-CoV-2 infection: a comparative study of the Wuhan and Omicron strains in K18-hACE2 Tg mice
by: Chae Won Kim, et al.
Published: (2025-04-01)

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
by: Challika Kaewborisuth, et al.
Published: (2022-05-01)

Evaluation and Its Impact of SARS-CoV-2 Inactivated Vaccine Candidate in K18-hACE2 Mice
by: Rofiqul A'la, et al.
Published: (2025-04-01)

Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
by: Haengdueng Jeong, et al.
Published: (2022-11-01)

Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice
by: Byeongseok Kim, et al.
Published: (2023-01-01)

Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications
by: Zeyu Sun, et al.
Published: (2021-10-01)

SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways
by: Hussin A. Rothan, et al.
Published: (2022-02-01)

A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic miceResearch in context
by: Seunghoon Choi, et al.
Published: (2024-01-01)

Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
by: Sebenzile K. Myeni, et al.
Published: (2024-07-01)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022-08-01)

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityResearch in context
by: Fernanda Ana-Sosa-Batiz, et al.
Published: (2025-03-01)

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19
by: Yasmin Silva-Santos, et al.
Published: (2024-07-01)